Austin, TX, November 8, 2024 – Dynamic Light, Inc. announces completion of a Patent and Software License Agreement with the University of Texas at Austin for all Intellectual Property related to the Company’s SpeckleView® Technology on an exclusive and world-wide basis. The technology developed under the leadership of Andrew Dunn, PhD, Professor, Director of Center for Emerging Imaging Technologies, Associate Chair of Research, UT Biomedical Engineering Department, allows for visualization of continuous real-time blood flow and tissue perfusion during a variety of surgical procedures, without the use of injectable contrast dyes.
Steve Whitlock, CEO, states, “Dynamic Light is excited to partner with UT Austin and looks forward to full development and commercial launch of our resulting product line in the US and Global marketplace to the benefit of both parties, and more importantly to patients.”
The licensing agreement was managed and finalized by Discovery to Impact, UT Austin’s connection unit between campus innovators and industry.
“We are pleased to support the licensing of UT Austin technology, SpeckleView®, to Dynamic Light, Inc. This collaboration reflects our commitment to fostering innovation and advancing research applications in the industry. We believe that partnerships like this are essential for driving progress and creating solutions to change the world,” said Mark Arnold, Associate Vice President for Discovery to Impact.
About Dynamic Light:
Dynamic Light, Inc. is a software and medical technology hardware based surgical system that enables continuous, real-time, high resolution visual insight into blood flow and perfusion during microsurgery applications without requiring traditional injectable dyes. Our revolutionary SpeckleView® Technology improves patient outcomes and reduces surgical errors and interruptions.
Please visit our newly launched web site at www.dynamiclight.com to learn more about our company.
